Evid Based Nurs 7:50 doi:10.1136/ebn.7.2.50
  • Treatment

Review: regular inhaled short acting β2 agonists improve lung function in stable chronic obstructive pulmonary disease

 Q Is regular treatment with inhaled short acting β2 agonists (ISABAs) effective for stable chronic obstructive pulmonary disease (COPD)?


GraphicData sources:

Cochrane Collaboration trials register up to and including May 2002 and reference lists of review articles and retrieved studies.

GraphicStudy selection and assessment:

randomised, placebo controlled trials of ISABAs given to patients with stable COPD for ⩾7 days. Individual study quality was assessed on the basis of allocation concealment.


forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), peak expiratory flow rate (PEFR), breathlessness (visual analogue scale), treatment failure, and patient preference.


13 crossover trials met the …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article